Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Effects of vaginal estradiol tablets and moisturizer on menopause-specific quality of life and mood in healthy postmenopausal women with vaginal symptoms: a randomized clinical trial.

Diem SJ, Guthrie KA, Mitchell CM, Reed SD, Larson JC, Ensrud KE, LaCroix AZ.

Menopause. 2018 Oct;25(10):1086-1093. doi: 10.1097/GME.0000000000001131.

2.

Efficacy of Vaginal Estradiol or Vaginal Moisturizer vs Placebo for Treating Postmenopausal Vulvovaginal Symptoms: A Randomized Clinical Trial.

Mitchell CM, Reed SD, Diem S, Larson JC, Newton KM, Ensrud KE, LaCroix AZ, Caan B, Guthrie KA.

JAMA Intern Med. 2018 May 1;178(5):681-690. doi: 10.1001/jamainternmed.2018.0116.

3.

Sexual frequency and pain in a randomized clinical trial of vaginal estradiol tablets, moisturizer, and placebo in postmenopausal women.

Mitchell CM, Guthrie KA, Larson J, Diem S, LaCroix AZ, Caan B, Shifren JL, Woods NF, Heiman JR, Lindau ST, Reed SD.

Menopause. 2019 Apr 15. doi: 10.1097/GME.0000000000001341. [Epub ahead of print]

PMID:
30994576
4.

Effects of estrogen and venlafaxine on menopause-related quality of life in healthy postmenopausal women with hot flashes: a placebo-controlled randomized trial.

Caan B, LaCroix AZ, Joffe H, Guthrie KA, Larson JC, Carpenter JS, Cohen LS, Freeman EW, Manson JE, Newton K, Reed S, Rexrode K, Shifren J, Sternfeld B, Ensrud K.

Menopause. 2015 Jun;22(6):607-15. doi: 10.1097/GME.0000000000000364.

5.

Effects of bazedoxifene/conjugated estrogens on quality of life in postmenopausal women with symptoms of vulvar/vaginal atrophy.

Bachmann G, Bobula J, Mirkin S.

Climacteric. 2010 Apr;13(2):132-40. doi: 10.3109/13697130903305627.

PMID:
19863455
6.

Evaluation of the measurement model and clinically important differences for menopause-specific quality of life associated with bazedoxifene/conjugated estrogens.

Bushmakin AG, Abraham L, Pinkerton JV, Cappelleri JC, Mirkin S.

Menopause. 2014 Aug;21(8):815-22. doi: 10.1097/GME.0000000000000176.

PMID:
24378765
7.

Oral 17β-estradiol/progesterone (TX-001HR) and quality of life in postmenopausal women with vasomotor symptoms.

Simon JA, Kaunitz AM, Kroll R, Graham S, Bernick B, Mirkin S.

Menopause. 2019 May;26(5):506-512. doi: 10.1097/GME.0000000000001271.

PMID:
30489424
8.

A randomized, double-blind, placebo-controlled trial of Chinese herbal medicine granules for the treatment of menopausal symptoms by stages.

Fu SF, Zhao YQ, Ren M, Zhang JH, Wang YF, Han LF, Chang YX, Fan GW, Wang H, Huang YH, Zhai JB, Dong JY, Li X, Ai JQ, Zhang H, Zhu Y, Zhang BL, Sun LK, Fan X, Gao XM.

Menopause. 2016 Mar;23(3):311-23. doi: 10.1097/GME.0000000000000534.

PMID:
26671188
9.

Menopause-specific quality of life across varying menopausal populations with conjugated estrogens/bazedoxifene.

Abraham L, Pinkerton JV, Messig M, Ryan KA, Komm BS, Mirkin S.

Maturitas. 2014 Jul;78(3):212-8. doi: 10.1016/j.maturitas.2014.04.008. Epub 2014 Apr 26. Erratum in: Maturitas. 2014 Dec;79(4):488.

PMID:
24837362
10.
11.

Menopausal quality of life: RCT of yoga, exercise, and omega-3 supplements.

Reed SD, Guthrie KA, Newton KM, Anderson GL, Booth-LaForce C, Caan B, Carpenter JS, Cohen LS, Dunn AL, Ensrud KE, Freeman EW, Hunt JR, Joffe H, Larson JC, Learman LA, Rothenberg R, Seguin RA, Sherman KJ, Sternfeld BS, LaCroix AZ.

Am J Obstet Gynecol. 2014 Mar;210(3):244.e1-11. doi: 10.1016/j.ajog.2013.11.016. Epub 2013 Nov 8.

12.

Effects of escitalopram on menopause-specific quality of life and pain in healthy menopausal women with hot flashes: a randomized controlled trial.

LaCroix AZ, Freeman EW, Larson J, Carpenter JS, Joffe H, Reed SD, Newton KM, Seguin RA, Sternfeld B, Cohen L, Ensrud KE.

Maturitas. 2012 Dec;73(4):361-8. doi: 10.1016/j.maturitas.2012.09.006. Epub 2012 Sep 30.

13.

The effects of Chinese medicinal herbs on postmenopausal vasomotor symptoms of Australian women. A randomised controlled trial.

Davis SR, Briganti EM, Chen RQ, Dalais FS, Bailey M, Burger HG.

Med J Aust. 2001 Jan 15;174(2):68-71.

PMID:
11245505
14.
15.

Efficacy of Transdermal Estradiol and Micronized Progesterone in the Prevention of Depressive Symptoms in the Menopause Transition: A Randomized Clinical Trial.

Gordon JL, Rubinow DR, Eisenlohr-Moul TA, Xia K, Schmidt PJ, Girdler SS.

JAMA Psychiatry. 2018 Feb 1;75(2):149-157. doi: 10.1001/jamapsychiatry.2017.3998.

16.

Efficacy and safety of a non-hormonal intravaginal moisturizer for the treatment of vaginal dryness in postmenopausal women with sexual dysfunction.

Vale F, Rezende C, Raciclan A, Bretas T, Geber S.

Eur J Obstet Gynecol Reprod Biol. 2019 Mar;234:92-95. doi: 10.1016/j.ejogrb.2018.12.040. Epub 2019 Jan 11.

PMID:
30677618
17.

Efficacy of intravaginal dehydroepiandrosterone (DHEA) on moderate to severe dyspareunia and vaginal dryness, symptoms of vulvovaginal atrophy, and of the genitourinary syndrome of menopause.

Labrie F, Archer DF, Koltun W, Vachon A, Young D, Frenette L, Portman D, Montesino M, Côté I, Parent J, Lavoie L, Beauregard A, Martel C, Vaillancourt M, Balser J, Moyneur É; VVA Prasterone Research Group.

Menopause. 2016 Mar;23(3):243-56. doi: 10.1097/GME.0000000000000571.

PMID:
26731686
18.

Microdose transdermal estrogen therapy for relief of vulvovaginal symptoms in postmenopausal women.

Bachmann GA, Schaefers M, Uddin A, Utian WH.

Menopause. 2009 Sep-Oct;16(5):877-82. doi: 10.1097/gme.0b013e3181a15606.

PMID:
19458560
19.

A comparison of the effects of oral conjugated equine estrogen and transdermal estradiol-17 beta combined with an oral progestin on quality of life in postmenopausal women.

Hilditch JR, Lewis J, Ross AH, Peter A, van Maris B, Franssen E, Charles J, Norton P, Dunn EV.

Maturitas. 1996 Jul;24(3):177-84.

PMID:
8844631
20.

Supplemental Content

Support Center